ACC HNC app for iPhone and iPad

Head and neck cancer is a dreadful disease across the world. Disease has poor prognosis. Conventionally disease is treated with cisplatin based chemotherapy regimens. However, not all the patients are suitable to cisplatin based chemotherapy. With evolving guidelines and clinical evidences, it’s observed that cisplatin may lead to acute as well as late toxicities, poor treatment adherence and even treatment related deaths. Proposed app is based on internationally published consensus recommendation criteria to identify cisplatin contra-indications and high risks (Ref: Oral Oncology 53 (2016) 10–16). App will assist physicians to individually validate clinical criteria of each and every patient based on given limits in published guidelines and help determine if the patient is suitable to cisplatin. Patients found unsuitable or contraindicated to cisplatin can be given alternate regimen and can be saved from treatment related side effects.